Then, we evaluated the effect of IRAK1 inhibitor pacritinib on the growth and proliferation of different cancer lines by the MTT assay, including MDA-MB-231, U251, Hep3B, Kyse30, and A498. The gene discussed is IRAK1; the disease is cancer.